Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Schnabl

Showing results (161-170 of 258) with videos related to

Pageof 26
Sort By:
Alcoholism, Clinical and Experimental Research|November 12, 2019
A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic HepatitisShinji Furuya, Josepmaria Argemi, Takeki Uehara, et al.
Nuclear Medicine and Biology|February 14, 2016
Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat modelsBernd Schnabl, Salman Farshchi-Heydari, Rohit Loomba, et al.
British Journal of Pharmacology|November 16, 2017
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver diseaseWeijun Wang, Jinfang Zhao, Wenfang Gui, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 7, 2025
Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose bingeGreta Karoline Viebahn, Amit Khurana, Linton Freund, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 10, 2015
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic SteatohepatitisAhilan Arulanandan, Brandon Ang, Ricki Bettencourt, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2026
Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver diseaseHenriette Kreimeyer, Marcos F Fondevila, Aenne Harberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in miceKatharina Brandl, Wataru Tomisato, Xiaohong Li, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 30, 2011
Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinaseDavid A Brenner, Ekihiro Seki, Kojiro Taura, et al.
Hepatology (Baltimore, Md.)|February 15, 2013
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in micePhillipp Hartmann, Peng Chen, Hui J Wang, et al.
Cell Reports|March 16, 2022
RORγt phosphorylation protects against T cell-mediated inflammationShengyun Ma, Shefali A Patel, Yohei Abe, et al.
Pageof 26

Showing results (161-170 of 258) with videos related to

Sort By:
Pageof 26
Alcoholism, Clinical and Experimental Research|November 12, 2019
A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic HepatitisShinji Furuya, Josepmaria Argemi, Takeki Uehara, et al.
Nuclear Medicine and Biology|February 14, 2016
Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat modelsBernd Schnabl, Salman Farshchi-Heydari, Rohit Loomba, et al.
British Journal of Pharmacology|November 16, 2017
Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver diseaseWeijun Wang, Jinfang Zhao, Wenfang Gui, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 7, 2025
Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose bingeGreta Karoline Viebahn, Amit Khurana, Linton Freund, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 10, 2015
Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic SteatohepatitisAhilan Arulanandan, Brandon Ang, Ricki Bettencourt, et al.
JHEP Reports : Innovation in Hepatology|April 17, 2026
Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver diseaseHenriette Kreimeyer, Marcos F Fondevila, Aenne Harberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2012
Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in miceKatharina Brandl, Wataru Tomisato, Xiaohong Li, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 30, 2011
Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinaseDavid A Brenner, Ekihiro Seki, Kojiro Taura, et al.
Hepatology (Baltimore, Md.)|February 15, 2013
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in micePhillipp Hartmann, Peng Chen, Hui J Wang, et al.
Cell Reports|March 16, 2022
RORγt phosphorylation protects against T cell-mediated inflammationShengyun Ma, Shefali A Patel, Yohei Abe, et al.
Pageof 26